Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial. (2024). Asian Journal of Medical Sciences, 15(4), 70-77. https://doi.org/10.3126/ajms.v15i4.61970